Cite
HARVARD Citation
Liu, N. et al. (2022). Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma. Clinical and translational medicine. 12 (4), p. n/a. [Online].